BioMarin Pharmaceutical Inc. /
Alesta Therapeutics B.V.
BioMarin Pharmaceutical Inc. signed an agreement for Alesta Therapeutics B.V.
Source for the buyer and target: BioMarin Pharmaceutical Inc.
What happened
The deal for Alesta Therapeutics B.V. is signed, with BioMarin Pharmaceutical Inc. as the buyer, at a stated price of $275 million upfront cash amount and up to $215 million of future payments. [01]
The filing from BioMarin Pharmaceutical Inc. is dated Aug. 18, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
BioMarin Pharmaceutical Inc. signed an agreement for Alesta Therapeutics B.V.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly